The Emerging Landscape of Pneumococcal Vaccines: Serotype Replacement, Capsular Polysaccharides, and Next-Generation Approaches for Vaccine Design
Although pneumococcal conjugate vaccines have markedly reduced the incidence rate of Streptococcus pneumoniae infections, the bacterium still remains a predominant cause of pneumonia, sepsis, meningitis, and otitis media worldwide. Its persistence could be largely attributed to serotype replacement and the emergence of multidrug resistance. S. pneumoniae has more than 100 distinct serotypes, but the available vaccines protect against a limited subset, where uncovered nonvaccine serotypes continue to inflict high mortality and comorbidities especially in children and the elderly. This article has elucidated the role of capsular polysaccharide as the principal determinant of virulence and described its properties including distinct composition, structure, charge, and thickness. It further elaborated how these properties influence the immunogenicity of different serotypes and contribute to their underlying pathophysiology. On the one hand, the negative charge of capsular polysaccharides prevents complement protein-mediated opsonization, and on the other hand, bacteria can dynamically control capsule thickness, balancing immune evasion with colonization. Due to such properties, capsular polysaccharides have been widely utilized for vaccine design. Unlike proteins, capsular polysaccharides are not highly immunogenic and, therefore, coupled with various adjuvants and carrier proteins in different conjugate vaccine formulations. Together, this article reviewed the epidemiology of serotypes, structural composition along with immunogenic features of capsular polysaccharides, and conjugate vaccines. Further, novel vaccine strategies, including expansion of the valency of pneumococcal conjugate vaccines, multiepitope vaccine designs, and protein-based constructs, have been elaborated, which represent pivotal steps toward reducing the infection rate of S. pneumoniae.
Authors
- Yogeshwar Devarakonda
- Kirtimaan Syal (ORCID: https://orcid.org/0000-0002-0046-0205)
- Shubham Kumar Sinha (ORCID: https://orcid.org/0009-0005-8349-832X)
- Ajita Rathi
- MVN Janardhan Reddy
Institutions
- Birla Institute of Technology and Science - Hyderabad Campus (IN)
- Birla Institute of Technology and Science, Pilani (IN)
Publication Details
- Journal
- ACS Omega
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1021/acsomega.6c09792
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Research Foundation
- Department of Biotechnology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
- University Grants Commission
- Birla Institute of Technology and Science, Pilani
- Science and Engineering Research Board